Title:
HUMAN ANTI-CANCER IMMUNOTHERAPY
Document Type and Number:
WIPO Patent Application WO2005115447
Kind Code:
A3
Abstract:
The present invention encompasses compositions and methods for activating, stimulating and isolating antigen-specific T cells. The present invention also relates to compositions of antigen-specific T cells and methods of their use in the treatment and prevention of cancer, infectious diseases, autoimmune diseases, immune disfunction related to aging, or any other disease state where antigen-specific T cells are desired for treatment.
Inventors:
VONDERHEIDE ROBERT H (US)
BEATTY GREGORY (US)
COUGHLIN CHRISTINA (US)
BEATTY GREGORY (US)
COUGHLIN CHRISTINA (US)
Application Number:
PCT/US2005/018395
Publication Date:
February 02, 2006
Filing Date:
May 25, 2005
Export Citation:
Assignee:
UNIV PENNSYLVANIA (US)
VONDERHEIDE ROBERT H (US)
BEATTY GREGORY (US)
COUGHLIN CHRISTINA (US)
VONDERHEIDE ROBERT H (US)
BEATTY GREGORY (US)
COUGHLIN CHRISTINA (US)
International Classes:
A61K39/00; C12N5/0783; (IPC1-7): A61K48/00; A61K39/00; A61K39/385; C12N15/63; C12N15/85; G01N33/53
Domestic Patent References:
| WO2002083921A2 | 2002-10-24 | |||
| WO2003060081A2 | 2003-07-24 |
Download PDF:
Previous Patent: DETECTION AND USE OF PROLYLCARBOXYPEPTIDASE
Next Patent: MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS
Next Patent: MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS